In fact, exo-ITGA5 and exo-ITGB3 (AUC of 0.95 and 0.98, respectively) performed better than exo-FOLR1 (AUC of 0.925) which was a robust ovarian cancer biomarker based on our previous work32. This evidence concerns the gene ITGB3 and ovarian carcinoma.